However, administration of S1P1 agonist in SphK2−/− mice markedly suppressed CFTR expression, abolished the protective effect of SphK2 deficiency on small airways remodeling and pulmonary inflammation after CS exposure. The gene discussed is S1PR1; the disease is inflammatory response.